Showing results (61-70 of 161) with videos related to

Sort By:
Pageof 17
Microbiology Spectrum|March 24, 2022
Emergence of High-Level Cefiderocol Resistance in Carbapenem-Resistant Klebsiella pneumoniae from Bloodstream Infections in Patients with Hematologic Malignancies in ChinaPeng Lan, Ye Lu, Zhongju Chen, et al.
Antimicrobial Agents and Chemotherapy|October 11, 2023
bla KPC-2 overexpression and bla GES-5 carriage as major imipenem/relebactam resistance mechanisms in Pseudomonas aeruginosa high-risk clones ST463 and ST235, respectively, in ChinaYue Li, Li Fang, Mengqian Dong, et al.
Antibiotics (Basel, Switzerland)|February 25, 2023
Emergence and Evolution of OXA-23-Producing ST46Pas-ST462Oxf-KL28-OCL1 Carbapenem-Resistant Acinetobacter baumannii Mediated by a Novel ISAba1-Based Tn7534 TransposonHaiyang Liu, Xiaochen Liu, Jintao He, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 17, 2022
A novel KPC-113 variant conferring carbapenem and ceftazidime-avibactam resistance in a multidrug-resistant Pseudomonas aeruginosa isolateQing Yang, Yue Li, Li Fang, et al.
Microbiology Spectrum|August 24, 2022
Plasmid-Borne AFM Alleles in Pseudomonas aeruginosa Clinical Isolates from ChinaMinhua Chen, Heng Cai, Yue Li, et al.
Protein and Peptide Letters|August 6, 2008
Biochemical characterization of two DNA ligases from Deinococcus radioduransDonghai Le, Xiaoting Hua, Lifen Huang, et al.
International Journal of Antimicrobial Agents|July 23, 2021
Acinetobacter baumannii strains isolated from cerebrospinal fluid (CSF) and bloodstream analysed by cgMLST: the dominance of clonal complex CC92 in CSF infectionsTao Chen, Ying Fu, Xiaoting Hua, et al.
Antimicrobial Agents and Chemotherapy|November 15, 2022
Structural Basis of PER-1-Mediated Cefiderocol Resistance and Synergistic Inhibition of PER-1 by Cefiderocol in Combination with Avibactam or Durlobactam in Acinetobacter baumanniiXiaochen Liu, Tailong Lei, Yunxing Yang, et al.
Infection|November 8, 2024
In vivo divergent evolution of cross-resistance to new β-lactam/β-lactamase inhibitor combinations in Pseudomonas aeruginosa following ceftazidime/avibactam treatmentHeng Cai, Minhua Chen, Yue Li, et al.
The Journal of Antimicrobial Chemotherapy|October 15, 2020
Acquisition of a genomic resistance island (AbGRI5) from global clone 2 through homologous recombination in a clinical Acinetobacter baumannii isolateXiaoting Hua, Robert A Moran, Qingye Xu, et al.
Pageof 17